Hbk Sorce Advisory LLC Verona Pharma PLC Transaction History
Hbk Sorce Advisory LLC
- $2.56 Billion
- Q3 2024
A detailed history of Hbk Sorce Advisory LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 7,353 shares of VRNA stock, worth $423,018. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,353Holding current value
$423,018% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
172Shares Held
68.6MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$363 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$321 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$288 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$243 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$204 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.51B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...